-
Drug Alert: 70 Drug Samples Fail To Clear CDSCO Test, 1 Declared spurious
23 Apr 2025 19:45 GMT
… 1940.
List of Drugs, Medical Devices, Vaccine and … ;s. Pace Biotech Village
Surajpur, Paonta Sahib … K.). Manufatured for : Pharmaceuticals and Medical Devices Bureau of India … India
68.
Chlorpheniramine Maleate Dextromethorphan Hydrobromide &
Phenylephrine HCl …
-
Regulator bans 35 combination drugs over safety issues
16 Apr 2025 21:46 GMT
… said.
FDCs-medicines that combine two or more drugs into a single … + metoprolol succinate for hypertension, and dextromethorphan hydrobromide + phenylephrine hydrochloride used to … and may lead to adverse drug reactions, drug interactions, and other health …
-
Americans Eligible for $4.5 Million Cough Medicine Settlement: Here's Who Qualifies
16 Apr 2025 19:11 GMT
… consumers who purchased Robitussin cough medicine products that were falsely marketed … ," while the presence of dextromethorphan (DXM)—a compound known to …
-
Govt Bans 35 Combination Drugs, See Full List
16 Apr 2025 17:57 GMT
… provisions of the New Drugs and Clinical Trials (NDCT) Rules, … CDSCO (FDC Division), from FDA Bhawan, New Delhi.
“ …
FDC of: (i) Dextromethorphan Hydrobromide IP 10mg + Phenylephrine … Ambroxol Hydrochloride IP 20mg + Dextromethorphan Hydrobromide IP 10m + Chlor …
-
CDSCO asks States and UTs to act upon list of 35 FDCs declared as new drugs
16 Apr 2025 05:06 GMT
… provisions of the New Drugs and Clinical Trials (NDCT) Rules, … 2019.
The national drug regulator … and efficacy by Central Drugs Standard Control Organisation ( … and dapagliflozin 10 mg; dextromethorphan hydrobromide 10 mg along …
-
AAN 2025: Axsome Therapeutics’ treatment for Alzheimer’s agitation shows promise
09 Apr 2025 10:25 GMT
… (bupropion + dextromethorphan) for the treatment of agitation … US Food and Drug Administration (FDA) granted AXS … often prescribed antipsychotic medications and sedatives … Pharmaceuticals’ Rexulti (brexpiprazole) became the first FDA-approved treatment …
-
Axsome Therapeutics to present positive phase 3 results of ACCORD─2 trial of AXS─05 in AD agitation and SYMPHONY trial of AXS─12 in narcolepsy at the 2025 AAN meeting
07 Apr 2025 13:00 GMT
… pivotal SYMPHONY phase 3 trial of AXS-12 in … of Medicine, New York, NY -- Session Name: Clinical Trials … formulation and dose of dextromethorphan and bupropion, and Axsome … Food and Drug Administration (FDA) Orphan Drug Designation for the treatment of …
-
Axsome Therapeutics Presents Positive Pivotal Phase 3 Results of the ACCORD-2 Trial of AXS-05 in Alzheimer’s Disease Agitation and the SYMPHONY Trial of AXS-12 in Narcolepsy at the 2025 American Academy of Neurology (AAN) Annual Meeting
04 Apr 2025 11:00 GMT
… antidepressant medicines called SSRIs or SNRIs. Stop taking SYMBRAVO and call your doctor … and dose of dextromethorphan and bupropion, … and Drug Administration (FDA) Orphan Drug Designation for the treatment … clinical trials and anticipated clinical trials for …
-
Revolutionizing cold and flu treatment with plant-based aspirin
21 Mar 2025 20:41 GMT
… problem with conventional medications
Surprisingly, most … cold and flu drugs—like dextromethorphan, phenylephrine, pseudoephedrine, … drugs cause drowsiness, dizziness, or rebound congestion. However, in a clinical trial … cold and flu treatments, paving the …
-
Treatment Resistant Depression FDA Approvals, Clinical Trials, Pipeline Insights, Companies
05 Feb 2025 23:00 GMT
… antidepressant compared with an oral antidepressant … Pharmaceuticals, Inc., Taisho Pharmaceutical Co … Treatment Resistant Depression Clinical Trials
Treatment Resistant Depression Emerging Drugs … dextromethorphan (DM) and bupropion. The dextromethorphan …
About
© 1995-2025